Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
7.43Cash Ratio
VS
Market
Sector
Industry
History
$ 2.05Close
$ 1.52 - $ 4.62 52-Week Range
Ticker Information
Ticker
MREOCompany Name
MEREO BIOPHARMA GROUP PLCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQMEREO BIOPHARMA GROUP PLC - Cash Ratio Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
MREO - Cash Ratio Historical data
| Date | Cash and Equivalents | Cash Ratio | Current Liabilities |
|---|---|---|---|
| 6/30/2025 | $ 56.13M | 7.43 | $ 7.56M |
| 3/31/2025 | $ 62.48M | 8.33 | $ 7.5M |
| 12/31/2024 | $ 69.8M | 5.04 | $ 13.85M |
| 9/30/2024 | $ 80.52M | 5.67 | $ 14.21M |
| 6/30/2024 | $ 87.43M | 5.65 | $ 15.47M |
| 3/31/2024 | $ 48.66M | 4.42 | $ 11M |
| 12/31/2023 | $ 57.42M | 6.05 | $ 9.49M |
| 6/30/2023 | $ 52.64M | 2.41 | $ 21.82M |
| 12/31/2022 | $ 70.42M | 2.28 | $ 30.85M |
| 6/30/2022 | $ 95.52M | 2.17 | $ 44.01M |
Key Performance Insights, Last 5 Years
- MEREO BIOPHARMA GROUP PLC's latest trailing twelve months (TTM) Cash Ratio stands at 2.74.
- Over the past 5 years, MEREO BIOPHARMA GROUP PLC's average Cash Ratio has been 5.45.
- The median Cash Ratio for MEREO BIOPHARMA GROUP PLC during this period was 5.65
- MEREO BIOPHARMA GROUP PLC reached its highest Cash Ratio over the past 5 years at 11.15.
- The lowest Cash Ratio recorded by MEREO BIOPHARMA GROUP PLC in the same timeframe 2.17
MEREO BIOPHARMA GROUP PLC's Cash Ratio vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
Cash Ratio Benchmarks
Similar metrics to LiabilitesC:
- Current Ratio - [Calculation] The current ratio is a liquidity indicator that describes the company’s ability to pay short-term obligations due within one year. Calculated by dividing current assets [AssetsC] by current liabilities [LiabilitiesC].
- Current Liabilities - [Balance Sheet] The current (short-term) portion of [Liabilities] includes obligations that are due to be paid to creditors within one year, reported if the company operates a classified balance sheet that segments current and non-current [Liabilities]
- Quick Ratio - [Calculation] The quick ratio is a liquidity indicator that describes the company’s ability to pay short-term obligations without the need to sell its inventory or receive additional financing. Calculated by dividing current assets [AssetsC] minus [Inventory] by current liabilities [LiabilitiesC].
- Cash to Assets Ratio - [Calculation] The Cash to Assets Ratio expresses a company’s cash and cash equivalents [CashnEq] as a percentage of total [Assets].
- Total Liabilities - [Balance Sheet] Total liabilities are the sum of all possible claims against the company. Common examples are [Debt], [Payables], deferred revenues, issued bonds, warranties, and tax liabilities.
Definition of Cash Ratio
[Calculation] The Cash Ratio is a liquidity indicator that describes a company's ability to meet short-term obligations with cash and cash equivalents. Calculated by dividing cash and cash equivalents [CashnEq] by current liabilities [LiabilitiesC].CashnEq / LiabilitesC
(=) Cash Ratio Cash Ratio for MEREO BIOPHARMA GROUP PLC is calculated as follows: CashnEq [ $ 29.34M ] / LiabilitesC [ $ 10.71M ]
(=) Cash Ratio [ 2.74 ] MREO - Cash Ratio, Last 5 years
2.17
Minimum
Jun 30, 2022
11.15
Maximum
Jun 30, 2021
5.45
Average
5.65
Median
Cash Ratio Benchmark AnalysisMarket
The chart above depicts the distribution of Cash Ratio for companies in the Total Stock Market. The average Cash Ratio of the companies is 0.62 with a standard deviation of 0.63.
The following table provides additional summary stats:
Cash Ratio in the Market:
| filtered constituents | 3.13K |
|---|---|
| min | 0 |
| max | 2.69 |
| average | 0.62 |
| median | 0.39 |
| std | 0.63 |